Skip to content
10-K

Annual Report

BIOAGE LABS, INC. BIOA

0000950170-25-042759

← back to feed
Filed
Mar 20, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 17, 2025 35.85M sh
Shares Diluted FY 2024 · Dec 31, 2023 1.67M sh
Capex FY 2024 · Dec 31, 2023 $166K
Operating Cash Flow FY 2024 · Dec 31, 2023 −$37.36M
Long Term Debt FY 2024 · Dec 31, 2023 $8.2M
Short Term Debt FY 2024 · Dec 31, 2023 $6M
Cash And Equivalents FY 2024 · Dec 31, 2023 $21.64M
Current Liabilities FY 2024 · Dec 31, 2023 $58.17M
Total Liabilities FY 2024 · Dec 31, 2023 $66.6M
Current Assets FY 2024 · Dec 31, 2023 $25.31M
Total Assets FY 2024 · Dec 31, 2023 $25.92M
Eps Diluted FY 2024 · Dec 31, 2023 −$38.17
Eps Basic FY 2024 · Dec 31, 2023 −$38.17
Sga Expense FY 2024 · Dec 31, 2023 $14.51M
Rd Expense FY 2024 · Dec 31, 2023 $33.89M
Net Income FY 2024 · Dec 31, 2023 −$63.85M
Operating Income FY 2024 · Dec 31, 2023 −$48.4M
Stockholders Equity FY 2024 · Dec 31, 2022 −$112.56M